Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Essex Bio-Technology (01061.HK) repurchased 28,000 shares for HK$56,300 on November 3.
03/11/2026
Zhitong Finance APP News, Essex Bio-Technology (01061.HK) announced that on November 3, 2026, it spent HK$56,300 to repurchase 28,000 shares.
Latest
13 m ago
HG partners with Anthropic to invest in a new AI startup.
15 m ago
Zhitong Finance APP News, Sunac Services (01516.HK) announced that on November 3, 2026, the company spent HK$134,900 to repurchase 200,000 shares at a repurchase price of HK$0.67-0.68 per share.
15 m ago
Zhitong Finance APP news, Yongan Futures (600927.SH) issued an announcement that on November 2, 2026, the company's wholly-owned overseas subsidiary Yongan International Financial (UK) Co. Limited received a notice from the UK Financial Conduct Authority (hereinafter referred to as "FCA"), approving the acquisition of FCA investment firm authorization to conduct, in the UK, for professional clients and eligible counterparties, regulated activities including trade matching, agency and principal dealing in commodity futures, commodity options and other derivatives, and holding client money.
18 m ago
Zhitong Finance APP News, Dongrui Pharmaceutical (02348.HK) announced that on November 3, 2026, it spent HK$92,500 to repurchase 100,000 shares.
22 m ago
China Resources Double-Crane (600062.SH): Isavuconazole Sulfate for Injection and Others Obtain Drug Registration Certificates
See all latest